Standard Clinical Guidelines for Hypertension, Type 2 Diabetes, and Asthma
Hypertension Management
The 2024 ESC guidelines and 2025 AHA/ACC guidelines represent the current standard for hypertension management, with diagnosis confirmed at ≥130/80 mmHg and treatment targets individualized based on patient characteristics. 1, 2
Blood Pressure Measurement and Diagnosis
- Measure BP with the patient seated after 5 minutes of rest, legs uncrossed, back supported, arm at heart level, after avoiding caffeine and tobacco for 30 minutes. 1
- Confirm elevated readings (≥130/80 mmHg) on a separate day before diagnosing hypertension. 1
- Out-of-office monitoring (home or ambulatory BP) is strongly recommended for diagnosis and ongoing management, as these measurements correlate better with cardiovascular outcomes than office readings. 1
- Use clinically validated oscillometric devices for automated measurement, though manual auscultatory methods remain the traditional standard. 1
Treatment Targets
- Target systolic BP <130 mmHg for most patients, with diastolic BP <80 mmHg. 1
- The 2024 ESC guidelines acknowledge that targets as low as 120-129 mmHg systolic may be appropriate based on patient characteristics and response to therapy. 1
Pharmacologic Management
- Initiate pharmacologic therapy immediately for BP ≥140/90 mmHg alongside lifestyle modifications. 1
- For BP 130-139/80-89 mmHg, attempt lifestyle therapy alone for maximum 3 months before adding medications. 1
- Multiple drug therapy (two or more agents at maximal doses) is generally required to achieve BP targets. 1
- Administer one or more antihypertensive medications at bedtime. 1
Type 2 Diabetes Management
The American Diabetes Association Standards of Care (updated annually through 2026) provide the evidence-based framework for diabetes management, with HbA1c targets generally <7% and metformin as first-line therapy. 3, 4, 5
Diagnostic Criteria and Monitoring
- Diagnose diabetes using standard criteria including fasting glucose, HbA1c, or oral glucose tolerance testing. 5
- Target HbA1c levels below 7% for most patients, with re-examination every 3-6 months. 6
Pharmacologic Treatment
- Metformin is the first-choice medical treatment if not contraindicated. 6
- The 2026 ADA Standards provide comprehensive pharmacologic approaches to glycemic treatment beyond metformin monotherapy. 4
Hypertension in Diabetic Patients
- For diabetic patients with hypertension, use either an ACE inhibitor or ARB as part of the regimen; if one class is not tolerated, substitute the other. 1
- Monitor kidney function and serum potassium levels when using ACE inhibitors, ARBs, or diuretics. 1
- For combination therapy in diabetic hypertension, calcium channel blockers (particularly novel molecules like cilnidipine) are recommended with ARBs rather than beta-blockers or diuretics to avoid cardiovascular events and hyperglycemia risk. 7
Lifestyle Modifications
- Implement DASH-style dietary pattern with reduced sodium and increased potassium intake. 1
- Initiate 50-60 minutes of exercise 3-4 times weekly, as physical activity demonstrates superior benefit for hypertension control in diabetic patients compared to dietary modification alone. 7
- Reduce intake of salt, sodium, and trans fats while increasing consumption of nuts, fresh fruits, vegetables, and potassium-rich foods. 7
Asthma Management
Local evidence-based guidelines disseminated through practice-based education improve asthma care, with focus on peak flow monitoring, inhaler technique review, symptom assessment, and appropriate prophylaxis. 8
Key Management Variables
- Record peak flow rate at each visit. 8
- Review inhaler technique regularly, as this shows consistent improvement with guideline implementation. 8
- Assess asthma symptoms systematically. 8
- Document and address smoking habit. 8
- Prescribe appropriate prophylaxis based on severity. 8
- Document occupation (for occupational asthma screening). 8